Our client had in developmental phase, a new treatment for a rare form of cancer.

The on going strategy was dependent on being able to assess treated prevalence, patient burden and treatment algorithms.

IMS HEOR assessed case history data with the IMS Oncology Analyzer database

supplemented this with targeted recruitment of new cases

conducted a telephone-based survey to increase the power of prevalence estimates.

Our client gained considerable insight into the major markets and now has a dossier with detailed treatment information and algorithms for 5 major markets.

reasonable estimates of prevalence

additional information that could be used to support a health economics case in the future.